Providing Regulatory Submissions in Alternate Electronic Format Guidance for Industry: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 24, 2022
June 24, 2022
c95b38e3-1b57-413c-b3fc-da380f4218da
Related Documents
Drug-Drug Interaction Assessment for Therapeutic Proteins Guidance for Industry: Guidance for Industry
Guidance DocumentJune 22, 2023Center for Drug Evaluation and Research
E8(R1) General Considerations for Clinical Studies
Guidance DocumentApril 8, 2022Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for Antibody-Drug Conjugates Guidance for Industry: Guidance for Industry
Guidance DocumentMarch 1, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox